| Breakdown | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 360.66B | 313.17B | 283.35B | 244.29B | 228.37B |
| Gross Profit | 159.59B | 138.71B | 126.25B | 104.67B | 91.32B |
| EBITDA | 82.81B | 79.74B | 70.05B | 56.22B | 49.77B |
| Net Income | 51.77B | 43.36B | 45.28B | 33.43B | 29.57B |
Balance Sheet | |||||
| Total Assets | 702.93B | 668.28B | 628.00B | 538.81B | 506.84B |
| Cash, Cash Equivalents and Short-Term Investments | 112.41B | 96.94B | 123.93B | 154.24B | 133.05B |
| Total Debt | 1.62B | 1.92B | 3.38B | 466.00M | 104.00M |
| Total Liabilities | 169.94B | 173.47B | 143.24B | 115.11B | 97.65B |
| Stockholders Equity | 515.37B | 478.39B | 458.89B | 409.31B | 395.72B |
Cash Flow | |||||
| Free Cash Flow | 49.90B | 19.09B | 21.66B | 28.48B | 26.52B |
| Operating Cash Flow | 65.33B | 51.62B | 43.35B | 45.40B | 53.46B |
| Investing Cash Flow | -24.90B | -18.46B | -62.71B | -9.18B | -36.03B |
| Financing Cash Flow | -31.33B | -39.30B | -11.63B | -19.13B | -12.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥1.27T | 25.57 | 11.19% | 1.12% | 15.16% | 20.06% | |
75 Outperform | ¥424.63B | 15.93 | ― | 0.33% | 7.20% | 49.11% | |
66 Neutral | ¥548.99B | 28.18 | ― | 1.12% | 1.10% | 16.74% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥26.65B | 9.01 | ― | 1.11% | -2.51% | -0.60% | |
55 Neutral | ¥142.28B | 28.98 | ― | 0.26% | 17.00% | ― | |
49 Neutral | ¥54.14B | 6.12 | 4.10% | 4.16% | 8.00% | 26.10% |